Retatrutide isn't supposed to be everywhere. Touted as the next generation in the GLP-1 craze, it's an experimental weight-loss drug that is not authorized outside of clinical trials. The Food and ...
The FDA has told Amgen that it is proposing to withdraw the approval of the rare disease drug Tavneos. The U.S. regulator is questioning the effectiveness and safety of Tavneos. It also says that its ...
The largest FDA-approved liquid biopsy panel, developed by Guardant Health, Inc.
The Food and Drug Administration in recent months has approved a small number of drugs quite quickly under a new expedited review program. But Health and Human Services Secretary Robert F. Kennedy Jr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results